Finorion Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 13 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Revenue 6.58%
(FY 2023)
- Profit 17.34%
(FY 2023)
- Ebitda 3.09%
(FY 2023)
- Net Worth 16.08%
(FY 2023)
- Total Assets 12.50%
(FY 2023)
About Finorion Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Olli Huotari, Johanna Pakkanen, Samrudhi Utturkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2011PTC225361
- Company No.
225361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2011
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Finorion Pharma India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samrudhi Utturkar  | Director | 29-May-2018 | Current |
Johanna Pakkanen  | Director | 24-Nov-2015 | Current |
| Olli Huotari | Director | 23-Dec-2011 | Current |
| Rene Lindell | Director | 31-Aug-2024 | Current |
Financial Performance of Finorion Pharma India.
Finorion Pharma India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.58% increase. The company also saw a substantial improvement in profitability, with a 17.34% increase in profit. The company's net worth Soared by an impressive increase of 16.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finorion Pharma India?
In 2023, Finorion Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Finorion Pharma India?
Finorion Pharma India has a workforce of 149 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Finorion Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finorion Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
